World's Best Scientists 2026 revealed!
VIEW LIST
Daniel Podzamczer

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Biology and Biochemistry 44 19220 17614 439 430 212 9723

Daniel Podzamczer publications per year

The chart shows the history of publications by Daniel Podzamczer between 1985 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Daniel Podzamczer published across 42 years, from 1985 to 2026, averaging 5.4 papers a year. Output peaked at 27 publications in 2012. 3 of the 226 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 1985 to 2026. Vertical axis: number of publications, 0 to 27. Peak 27 publications in 2012. 1985: 2 publications 1986: 0 publications 1987: 0 publications 1988: 1 publication 1989: 0 publications 1990: 2 publications 1991: 1 publication 1992: 1 publication 1993: 0 publications 1994: 1 publication 1995: 1 publication 1996: 3 publications 1997: 0 publications 1998: 0 publications 1999: 1 publication 2000: 2 publications 2001: 2 publications 2002: 2 publications 2003: 5 publications 2004: 4 publications 2005: 3 publications 2006: 3 publications 2007: 8 publications 2008: 4 publications 2009: 7 publications 2010: 8 publications 2011: 14 publications 2012: 27 publications 2013: 3 publications 2014: 15 publications 2015: 17 publications 2016: 10 publications 2017: 11 publications 2018: 11 publications 2019: 12 publications 2020: 13 publications 2021: 18 publications 2022: 5 publications 2023: 5 publications 2024: 1 publication 2025: 2 publications 2026: 1 publication
1985 2026

226 publications in total across all disciplines

View publications per year as a table
Daniel Podzamczer: publications per year, 1985 to 2026
Year Publications
1985 2
1986 0
1987 0
1988 1
1989 0
1990 2
1991 1
1992 1
1993 0
1994 1
1995 1
1996 3
1997 0
1998 0
1999 1
2000 2
2001 2
2002 2
2003 5
2004 4
2005 3
2006 3
2007 8
2008 4
2009 7
2010 8
2011 14
2012 27
2013 3
2014 15
2015 17
2016 10
2017 11
2018 11
2019 12
2020 13
2021 18
2022 5
2023 5
2024 1
2025 2
2026 1
Total 226
Download as CSV

Daniel Podzamczer publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Daniel Podzamczer sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 100 bars. Horizontal axis: publications, 47–56 to 1,028+. Vertical axis: number of scientists, 0 to 980. Most scientists, 980, have 127–136 publications. The last bar groups every scientist with 1,028 publications or more. The highlighted bar, 207–216 publications, is where this scientist sits. 47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientist 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientist 1,028+ publications: 100 scientists
47–56 publications 1,028+

This scientist: 212 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

View publications distribution as a table
Number of Biology and Biochemistry scientists by publication count, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
Publications Scientists This scientist
47–56 8
57–66 35
67–76 106
77–86 231
87–96 413
97–106 546
107–116 704
117–126 848
127–136 980
137–146 942
147–156 969
157–166 949
167–176 951
177–186 915
187–196 787
197–206 840
207–216 733 212
217–226 708
227–236 651
237–246 605
247–256 510
257–266 524
267–276 434
277–286 417
287–296 350
297–306 363
307–316 315
317–326 296
327–336 261
337–346 240
347–356 219
357–366 196
367–376 154
377–386 161
387–396 155
397–406 145
407–416 124
417–426 112
427–436 132
437–446 116
447–456 99
457–466 81
467–476 91
477–486 80
487–496 80
497–506 59
507–516 36
517–526 46
527–536 54
537–546 44
547–556 43
557–566 43
567–576 42
577–586 25
587–596 34
597–606 23
607–616 33
617–626 31
627–636 27
637–646 25
647–656 28
657–666 34
667–676 18
677–686 16
687–696 10
697–706 12
707–716 21
717–726 12
727–736 12
737–746 10
747–756 7
757–766 13
767–776 15
777–786 13
787–796 9
797–806 9
807–816 7
817–826 4
827–836 9
837–846 7
847–856 3
857–866 5
867–876 5
877–886 11
887–896 3
897–906 4
907–916 7
917–926 5
927–936 6
937–946 6
947–956 3
957–966 7
967–976 2
977–986 2
987–996 1
997–1,006 5
1,007–1,016 2
1,017–1,026 2
1,027 1
1,028+ 100
Download as CSV

Daniel Podzamczer D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel Podzamczer sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 65 bars. Horizontal axis: D-Index, 40–41 to 167+. Vertical axis: number of scientists, 0 to 1,253. Most scientists, 1,253, have 58–59 D-Index. The last bar groups every scientist with 167 D-Index or more. The highlighted bar, 44–45 D-Index, is where this scientist sits. 40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40–41 D-Index 167+

This scientist: 44 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

View D-Index distribution as a table
Number of Biology and Biochemistry scientists by D-index, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
D-Index Scientists This scientist
40–41 80
42–43 183
44–45 316 44
46–47 504
48–49 718
50–51 899
52–53 1,025
54–55 1,149
56–57 1,235
58–59 1,253
60–61 1,162
62–63 1,130
64–65 1,031
66–67 897
68–69 814
70–71 714
72–73 709
74–75 596
76–77 512
78–79 473
80–81 412
82–83 373
84–85 358
86–87 285
88–89 273
90–91 227
92–93 208
94–95 193
96–97 153
98–99 157
100–101 148
102–103 120
104–105 113
106–107 100
108–109 86
110–111 67
112–113 71
114–115 73
116–117 64
118–119 53
120–121 60
122–123 54
124–125 43
126–127 38
128–129 49
130–131 26
132–133 18
134–135 23
136–137 32
138–139 32
140–141 27
142–143 19
144–145 22
146–147 12
148–149 16
150–151 14
152–153 10
154–155 13
156–157 10
158–159 7
160–161 9
162–163 13
164–165 4
166 4
167+ 98
Download as CSV

Overview

Daniel Podzamczer is affiliated with Bellvitge University Hospital in Spain and has contributed extensively to medical research, particularly in the field of infectious diseases. Their research primarily addresses HIV/AIDS drug development, treatment, and related health complications.

The main fields of study covered by their work include:

  • Medicine
  • Immunology and Microbiology

Within these fields, the subfields of particular focus are:

  • Infectious Diseases
  • Virology
  • Emergency Medicine
  • Epidemiology
  • Oncology

The topics most frequently investigated by Daniel Podzamczer are:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV-related health complications and treatments
  • HIV/AIDS Research and Interventions
  • Viral-associated cancers and disorders
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Lipoproteins and Cardiovascular Health

Their recent significant publications include:

  • Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials (2020), The Lancet HIV
  • Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study (2021), The Lancet HIV
  • Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study (2021), Open Forum Infectious Diseases
  • Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial (2021), The Lancet HIV
  • Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: A pooled analysis of 26 clinical trials (2020), UNC Libraries

Frequent co-authors collaborating with Daniel Podzamczer include:

  • Estebán Martínez
  • María Saumoy
  • Peré Domingo
  • Mar Masiá
  • Juan Tiraboschi

They have published in several journals and venues, notably:

  • Journal of Antimicrobial Chemotherapy
  • Open Forum Infectious Diseases
  • The Lancet HIV
  • SSRN Electronic Journal
  • Journal of Pharmaceutical and Biomedical Analysis

Best Publications

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

    Paul E Sax;David Wohl;Michael T Yin;Frank Post

  • Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

    Francois Raffi;Anita Rachlis;Hans-Jürgen Stellbrink;W David Hardy

  • Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

    David A. Margolis;Juan Gonzalez-Garcia;Hans Jürgen Stellbrink;Joseph J. Eron

  • Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

    Joel Gallant;Adriano Lazzarin;Anthony Mills;Chloe Orkin

  • Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.

    J. Berenguer;P. Ryan;J. Rodríguez-Baño;I. Jarrín

  • Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.

    Frank A Post;Graeme J Moyle;Hans Jürgen Stellbrink;Pere Domingo

  • A prospective study of the risk of tuberculosis among HIV-infected patients.

    A Guelar;J M Gatell;J Verdejo;D Podzamczer

  • Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial.

    Sharon Walmsley;Axel Baumgarten;Juan Berenguer;Franco Felizarta

  • Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.

    Jean-Michel Molina;Douglas Ward;Indira Brar;Anthony Mills

  • Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

    José R Arribas;Pierre-Marie Girard;Roland Landman;Judit Pich

  • Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials.

    Samir K. Gupta;Frank A. Post;José R. Arribas;Joseph J. Eron

  • Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent

    Jing Yuan;Sheng Guo;David Hall;Anna M Cammett

  • Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

    Jean-Michel Molina;Kathleen Squires;Paul E Sax;Pedro Cahn

  • A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen.

    Margaret A. Johnson;Joseph C. Gathe;Daniel Podzamczer;Jean-Michel Molina

  • Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.

    Daniel Podzamczer;Albert Salazar;Josep Jimenez;Ezequiel Consiglio

  • Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.

    Richard B. Pollard;Jürgen K. Rockstroh;Giuseppe Pantaleo;David M. Asmuth

  • Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.

    Luz Martin-Carbonero;Ana Barrios;Pere Saballs;Guillem Sirera

  • Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial.

    Vicente Soriano;Keikawus Arasteh;Horacio Migrone;Thomas Lutz

  • Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).

    Jesús Rodríguez-Baño;Jerónimo Pachón;Jordi Carratalà;Pablo Ryan

Frequent Co-Authors

Pere Domingo
Pere Domingo Autonomous University of Barcelona
Jose R. Arribas
Jose R. Arribas Hospital Universitario La Paz
Bonaventura Clotet
Bonaventura Clotet IrsiCaixa
Hernando Knobel
Hernando Knobel Autonomous University of Barcelona
Juan Berenguer
Juan Berenguer Hospital General Universitario Gregorio Marañón
José M. Gatell
José M. Gatell University of Barcelona
José M. Miró
José M. Miró University of Barcelona
Santiago Moreno
Santiago Moreno Hospital Universitario Ramón y Cajal
Chloe Orkin
Chloe Orkin Queen Mary University of London
Federico Pulido
Federico Pulido Complutense University of Madrid

External Links

Personal website of Daniel Podzamczer

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens the door to a wide array of advanced online degrees and career options in healthcare and science. Students can seamlessly extend their education into specialized graduate or professional programs to boost their employability and impact in growing fields.

Those interested in healthcare management may consider enrolling in the top online mha programs that are cahme accredited, which deliver industry-recognized credentials for future healthcare leaders. If you are seeking a clinical doctorate with more flexibility, look into a dnp program without clinical hours, designed for working professionals seeking leadership roles in nursing.

Ambitious students can also advance into online doctoral programs healthcare administration, combining scientific knowledge with executive skills for senior positions in the healthcare sector. Pharmacology enthusiasts may pursue online pharmd programs to transition into high-demand pharmacy roles without attending traditional campus classes.

These related online degrees support a wide variety of career pathways and are ideal for science graduates looking to deepen their expertise, specialize, or move into healthcare leadership and policy.

Best Scientists Citing Daniel Podzamczer

Santiago Moreno

Santiago Moreno

Hospital Universitario Ramón y Cajal

Publications: 39

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 38

Paul E. Sax

Paul E. Sax

Brigham and Women's Hospital

Publications: 35

Chloe Orkin

Chloe Orkin

Queen Mary University of London

Publications: 35

Andrew Hill

Andrew Hill

University of Liverpool

Publications: 31

Andrea Antinori

Andrea Antinori

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Publications: 29

Jean-Michel Molina

Jean-Michel Molina

Université Paris Cité

Publications: 28

Kenneth H. Mayer

Kenneth H. Mayer

Harvard Medical School

Publications: 27

Jose R. Arribas

Jose R. Arribas

Hospital Universitario La Paz

Publications: 26

Juan Berenguer

Juan Berenguer

Hospital General Universitario Gregorio Marañón

Publications: 25

Joseph J. Eron

Joseph J. Eron

University of North Carolina at Chapel Hill

Publications: 22

Bonaventura Clotet

Bonaventura Clotet

IrsiCaixa

Publications: 22

Frank A. Post

Frank A. Post

King's College London

Publications: 22

José M. Miró

José M. Miró

University of Barcelona

Publications: 21

Pere Domingo

Pere Domingo

Autonomous University of Barcelona

Publications: 21

Giuliano Rizzardini

Giuliano Rizzardini

ASST Fatebenefratelli Sacco

Publications: 20

Trending Scientists

Junwu Zhu

Junwu Zhu

Nanjing University of Science and Technology

Erik Steen Jensen

Erik Steen Jensen

Swedish University of Agricultural Sciences

Christian M. Connell

Christian M. Connell

Pennsylvania State University

Mikko Laine

Mikko Laine

University of Bern

Bo Dupont

Bo Dupont

Kettering University

Riitta Parkkola

Riitta Parkkola

Turku University Hospital

Valerie B. O'Donnell

Valerie B. O'Donnell

Cardiff University

Susan Greenhalgh

Susan Greenhalgh

Harvard University

Alan Brown

Alan Brown

Harvard University

Theresa L. Osypuk

Theresa L. Osypuk

University of Minnesota

Robert C. Armstrong

Robert C. Armstrong

Sandia National Laboratories

Hervé Clavier

Hervé Clavier

Aix-Marseille University

Carine Michel

Carine Michel

Claude Bernard University Lyon 1

William F. Fearon

William F. Fearon

Stanford University

Paolo Domenici

Paolo Domenici

National Research Council (CNR)

Debra Ann Grace

Debra Ann Grace

Griffith University

Related Biology and Biochemistry Rankings & Guides

2027 Radiology Tech vs. Registered Nurse: Explaining the Difference

2027 Radiology Tech vs. Registered Nurse: Explaining the Difference
2027 How to Become a Cath Lab Tech: Education, Salary, and Job Outlook

2027 How to Become a Cath Lab Tech: Education, Salary, and Job Outlook
2027 Do Employers Pay for Pharmacy Degrees: Tuition Reimbursement and Sponsorship Options

2027 Do Employers Pay for Pharmacy Degrees: Tuition Reimbursement and Sponsorship Options
2027 Biotechnology Degree vs. Certificate: Which Should You Choose?

2027 Biotechnology Degree vs. Certificate: Which Should You Choose?
2027 Respiratory Therapist (RT) vs. Registered Nurse (RN): Explaining the Difference

2027 Respiratory Therapist (RT) vs. Registered Nurse (RN): Explaining the Difference
2027 Online Medical Billing & Coding Degree Programs Costs: Tuition & Fees

2027 Online Medical Billing & Coding Degree Programs Costs: Tuition & Fees
2027 Is a Healthcare Administration Online Degree Worth It?

2027 Is a Healthcare Administration Online Degree Worth It?
2027 Online Clinical Research Management Degree Programs Costs: Tuition & Fees

2027 Online Clinical Research Management Degree Programs Costs: Tuition & Fees
2027 How to Become a Wellness Coach: Education, Salary, and Job Outlook

2027 How to Become a Wellness Coach: Education, Salary, and Job Outlook
2027 Clinical vs. Administrative Medical Assistant: Explaining the Difference

2027 Clinical vs. Administrative Medical Assistant: Explaining the Difference
2027 Part-Time vs. Full-Time Ultrasound Technology Degree Programs

2027 Part-Time vs. Full-Time Ultrasound Technology Degree Programs
2027 Cheapest and Shortest Online Ultrasound Technology Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2027 Cheapest and Shortest Online Ultrasound Technology Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2027 Can You Get Into a Public Health Degree Master's Program with a Low GPA? Admission Chances & Workarounds

2027 Can You Get Into a Public Health Degree Master's Program with a Low GPA? Admission Chances & Workarounds
2027 Radiology Tech vs. Radiation Therapist: Explaining the Difference

2027 Radiology Tech vs. Radiation Therapist: Explaining the Difference
2027 Do Online Pharmacy Programs Offer Weekly Start Dates? Enrollment Calendar & Start Options

2027 Do Online Pharmacy Programs Offer Weekly Start Dates? Enrollment Calendar & Start Options
2027 Are There Any One-Year Online Medical Billing & Coding Degree Programs Worth Considering?

2027 Are There Any One-Year Online Medical Billing & Coding Degree Programs Worth Considering?
2027 Certified Nursing Assistant (CNA) vs. Registered Nurse (RN): Explaining the Difference

2027 Certified Nursing Assistant (CNA) vs. Registered Nurse (RN): Explaining the Difference
2027 Fastest Online Health Informatics Master's Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Health Informatics Master's Degree Programs You Can Finish in Under 2 Years
2027 How to Become an Epidemiologist: Education, Salary, and Job Outlook

2027 How to Become an Epidemiologist: Education, Salary, and Job Outlook
2027 Psychiatric Nurse Practitioner vs. Therapist: Explaining the Difference

2027 Psychiatric Nurse Practitioner vs. Therapist: Explaining the Difference
2027 Online Pharmacy Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations

2027 Online Pharmacy Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations

Recently Published Articles

2027 Cybersecurity Degree Coursework Explained: What Classes Can You Expect to Take?

2027 Cybersecurity Degree Coursework Explained: What Classes Can You Expect to Take?
2027 Best PsyD Programs in Delaware: APA Accredited Online & Campus

2027 Best PsyD Programs in Delaware: APA Accredited Online & Campus
2027 School Psychology Internship Requirements: Hours, Placements, and Supervision

2027 School Psychology Internship Requirements: Hours, Placements, and Supervision
2027 Military-Friendly Online Information Technology Master's Degree Programs: Benefits, Accreditation & Career Outcomes

2027 Military-Friendly Online Information Technology Master's Degree Programs: Benefits, Accreditation & Career Outcomes
2027 Fastest Online MSN Adult-Gerontology Acute Care NP Programs

2027 Fastest Online MSN Adult-Gerontology Acute Care NP Programs
2027 DBA vs. MBA: Explaining the Difference

2027 DBA vs. MBA: Explaining the Difference
2027 Is an Applied Behavior Analysis Master's Degree Worth It? ROI, Salary & Career Impact

2027 Is an Applied Behavior Analysis Master's Degree Worth It? ROI, Salary & Career Impact
2027 How Long Does It Take to Become an Architect?

2027 How Long Does It Take to Become an Architect?
2027 Construction Engineer vs. Construction Manager: Explaining the Difference

2027 Construction Engineer vs. Construction Manager: Explaining the Difference
2027 What Can You Do with a Nursing Education Master's Degree? Careers, Salaries & Growth

2027 What Can You Do with a Nursing Education Master's Degree? Careers, Salaries & Growth
2027 Online Applied Science Degree Programs With No Personal Statement or Admissions Essay Required

2027 Online Applied Science Degree Programs With No Personal Statement or Admissions Essay Required
2027 How to Become a BCBA in Port St. Lucie, FL: Education Requirements & Certification

2027 How to Become a BCBA in Port St. Lucie, FL: Education Requirements & Certification
2027 Teacher Certification Types & Requirements in Arkansas

2027 Teacher Certification Types & Requirements in Arkansas
2027 Most Affordable Master’s in Computer Science Online

2027 Most Affordable Master’s in Computer Science Online
2027 What Does a Cybersecurity Specialist Do: Responsibilities, Requirements, and Salary

2027 What Does a Cybersecurity Specialist Do: Responsibilities, Requirements, and Salary
2027 AI Master's Degrees for Product Managers

2027 AI Master's Degrees for Product Managers
2027 Cheapest and Shortest Online Real Estate Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2027 Cheapest and Shortest Online Real Estate Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2027 Is a Kinesiology Master's Degree Worth It? ROI, Salary & Career Impact

2027 Is a Kinesiology Master's Degree Worth It? ROI, Salary & Career Impact
2027 How to Become a Private School Teacher in Alabama: Requirements & Certification

2027 How to Become a Private School Teacher in Alabama: Requirements & Certification
2027 Shortest Online Social Psychology Degree Master's Programs That Pay Well: Cost, Time to Completion, and Salary Outlook

2027 Shortest Online Social Psychology Degree Master's Programs That Pay Well: Cost, Time to Completion, and Salary Outlook
2027 Nurse Administrator Degree Salary by Experience Level: Entry-Level, Mid-Career, and Senior Roles

2027 Nurse Administrator Degree Salary by Experience Level: Entry-Level, Mid-Career, and Senior Roles